A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. (2014)

First Author: Schönhuber N
Attributed to:  Exploitation of mouse models to validate protein kinases as drug targets funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nm.3646

PubMed Identifier: 25326799

Publication URI: http://europepmc.org/abstract/MED/25326799

Type: Journal Article/Review

Volume: 20

Parent Publication: Nature medicine

Issue: 11

ISSN: 1078-8956